Leadership Overview
Eurofins has 10 executives leading key functions including technology, financial oversight, operational management, and regional business leadership.
Focused on advancing global health through analytical testing, Eurofins delivers critical scientific support services across pharmaceutical, food, and environmental sectors to ensure safety and quality standards worldwide.
Focused on advancing global health through analytical testing, Eurofins delivers critical scientific support services across pharmaceutical, food, and environmental sectors to ensure safety and quality standards worldwide.
Leadership Roles at Eurofins
Jatin Vij - Chief Financial Officer, Business Lines (Multiple, Asia)
Jatin Vij, the Chief Financial Officer, Business Lines (Multiple, Asia) at Eurofins, manages fiscal strategy across the Asian market. Overseeing financial planning for multiple business lines, the Chief Financial Officer, Business Lines (Multiple, Asia) ensures capital allocation aligns with regional growth objectives. This leadership role involves monitoring revenue streams from food and environmental testing services to optimize profitability. By implementing robust financial controls, Jatin Vij supports the expansion of laboratory operations throughout the region. The Chief Financial Officer, Business Lines (Multiple, Asia) coordinates with local management to mitigate economic risks and enhance operational margins. Through rigorous budget oversight, Vij drives the financial health of the Asian division. This focus on fiscal discipline allows the company to scale testing capacity effectively, meeting the rising demand for high-quality scientific support services in rapidly developing markets while maintaining strict adherence to corporate financial policies.
Alexandra Kim - Chief Financial Officer, Business Line
Alexandra Kim, the Chief Financial Officer, Business Line at Eurofins, governs the financial performance of specific analytical testing units. Overseeing the budgetary requirements for specialized laboratory services, the Chief Financial Officer, Business Line ensures that resource distribution supports long-term scientific research goals. This leadership role involves analyzing cost structures to improve the efficiency of clinical diagnostics and pharmaceutical testing. By refining financial reporting processes, Alexandra Kim provides the executive team with actionable insights into market profitability. The Chief Financial Officer, Business Line collaborates with operational leads to streamline procurement and reduce overhead expenses. Through strategic financial modeling, Kim strengthens the economic foundation of the business line. This commitment to fiscal precision enables the organization to invest in advanced testing technologies, ensuring that the company remains a leader in providing essential scientific support services to global clients across various critical industries.
Elizabeth Winger - President
Elizabeth Winger, the President at Eurofins, directs the strategic vision for core analytical testing divisions. Overseeing the development of new service offerings, the President ensures that the company meets the evolving needs of the pharmaceutical and clinical diagnostics sectors. This leadership role involves fostering partnerships with key industry stakeholders to expand market reach. By aligning business objectives with scientific advancements, Elizabeth Winger drives the growth of the laboratory network. The President collaborates with other executive leaders to define long-term goals and ensure organizational cohesion. Through the promotion of innovation, Winger secures the position of the company as a premier provider of testing services. This strategic oversight enables the organization to navigate complex regulatory environments while maintaining high standards of service quality. By focusing on sustainable growth, the President ensures that the company continues to provide essential scientific support services to clients worldwide.
Takahiko Hagiwara - Group President (Japan)
Takahiko Hagiwara, the Group President (Japan) at Eurofins, leads all business activities within the Japanese market. Overseeing the expansion of laboratory facilities, the Group President (Japan) ensures that local operations align with the global mission of providing high-quality analytical testing. This leadership role involves managing relationships with domestic pharmaceutical and food industry clients. By tailoring service delivery to meet local regulatory requirements, Takahiko Hagiwara drives the success of the Japanese division. The Group President (Japan) coordinates with international teams to share best practices and technological advancements. Through the implementation of localized growth strategies, Hagiwara strengthens the market presence of the company. This focus on regional excellence allows the organization to provide specialized scientific support services that address the unique needs of the Japanese market. By fostering a culture of quality and innovation, the Group President (Japan) ensures the continued growth and stability of the regional business.
Jp Boutrand - President
Jp Boutrand, the President at Eurofins, manages the strategic direction of specialized testing business units. Overseeing the integration of new laboratory acquisitions, the President ensures that these facilities maintain the high standards of the company. This leadership role involves driving the commercial success of environmental and consumer product testing services. By identifying new market opportunities, Jp Boutrand expands the reach of the organization. The President collaborates with technical teams to enhance the capabilities of the laboratory network. Through the execution of growth initiatives, Boutrand improves the overall service portfolio. This focus on strategic development allows the company to provide comprehensive scientific support to a diverse range of clients. By maintaining a clear vision for the business unit, the President ensures that the organization remains at the forefront of the analytical testing industry, delivering reliable results that support public health and safety.
Marisa Feller - President
Marisa Feller, the President at Eurofins, oversees the operational and commercial strategy for key clinical diagnostics divisions. Overseeing the implementation of advanced testing methodologies, the President ensures that the company provides accurate and timely results to healthcare providers. This leadership role involves managing the performance of laboratory teams to meet rigorous quality standards. By fostering collaboration between scientific and commercial departments, Marisa Feller drives the growth of the diagnostics business. The President coordinates with regulatory bodies to ensure compliance with international health standards. Through the development of strategic partnerships, Feller expands the impact of the company in the clinical sector. This focus on service excellence allows the organization to support the diagnostic needs of patients and medical professionals. By prioritizing innovation and quality, the President ensures that the company remains a trusted partner in the global healthcare ecosystem.
Camila Gadotti - President
Camila Gadotti, the President at Eurofins, directs the strategic operations for food and environmental testing business lines. Overseeing the expansion of testing capabilities, the President ensures that the company provides essential safety data to the food industry. This leadership role involves managing the performance of laboratories to ensure compliance with global food safety regulations. By implementing efficient testing workflows, Camila Gadotti increases the capacity of the organization to handle large-scale analytical projects. The President collaborates with industry partners to address emerging food safety challenges. Through the execution of growth strategies, Gadotti strengthens the market position of the company. This focus on operational efficiency allows the organization to deliver reliable results that protect public health. By maintaining a commitment to scientific rigor, the President ensures that the company continues to provide critical support services to the global food and environmental sectors.
Cathy Poye - President, Eurofins J3 Resources, Inc
Cathy Poye, the President, Eurofins J3 Resources, Inc at Eurofins, manages the specialized operations of the J3 Resources division. Overseeing the delivery of environmental testing services, the President, Eurofins J3 Resources, Inc ensures that the laboratory meets the specific needs of clients requiring industrial hygiene and material analysis. This leadership role involves maintaining the technical expertise of the staff to provide accurate analytical data. By optimizing laboratory processes, Cathy Poye enhances the service quality of the division. The President, Eurofins J3 Resources, Inc coordinates with other business units to leverage the broader capabilities of the company. Through the implementation of client-focused strategies, Poye drives the growth of the J3 Resources business. This focus on specialized testing allows the organization to provide essential support to industrial and environmental sectors. By maintaining high standards of accuracy, the President, Eurofins J3 Resources, Inc ensures the continued success of the division.
Scott Fyfe - Chief Technology Officer
Scott Fyfe, the Chief Technology Officer at Eurofins, directs the digital transformation of laboratory infrastructure. Overseeing the integration of advanced data analytics into testing workflows, the Chief Technology Officer ensures that laboratory systems maintain peak efficiency. This leadership role involves architecting scalable cloud solutions to support the vast international network of testing facilities. By modernizing the technological backbone of the organization, Scott Fyfe directly impacts the speed and accuracy of clinical diagnostics. The Chief Technology Officer collaborates with global teams to implement automated testing protocols, reducing turnaround times for pharmaceutical clients. Through the deployment of cutting-edge software, Fyfe secures the competitive advantage of the company in the life sciences market. This strategic focus on digital innovation enables the organization to handle complex analytical demands across diverse consumer product sectors while maintaining rigorous data integrity standards.
Jamie Bendrick-Peart - Chief Operations Officer
Jamie Bendrick-Peart, the Chief Operations Officer at Eurofins, manages the daily performance of the international network of laboratories. Overseeing the standardization of testing protocols, the Chief Operations Officer ensures that every facility adheres to global quality benchmarks. This leadership role involves optimizing supply chain logistics to maintain the continuous flow of samples and reagents. By streamlining operational workflows, Jamie Bendrick-Peart increases the throughput of environmental and food testing services. The Chief Operations Officer coordinates with regional directors to resolve bottlenecks and enhance laboratory productivity. Through the implementation of lean management principles, Bendrick-Peart drives operational excellence across the entire organization. This focus on process improvement allows the company to deliver reliable analytical results to pharmaceutical and consumer product clients. By maintaining high operational standards, the Chief Operations Officer supports the overall mission of providing accurate and timely scientific support services on a global scale.
Explore Leadership Teams in Business Services
Genentech, based in South San Francisco, California, is a biotechnology company specializing in the development of innovative therapies for serious medical conditions. Founded in 1976, Genentech serves the healthcare sector with a focus on research and development of biopharmaceuticals to improve patient outcomes.
Company Leadership AM

LL
JH
A global leader in applied safety science, UL Solutions transforms safety, security and sustainability challenges into opportunities for customers. We deliver testing, inspection and certification services, plus software and advisory offerings that support our customers product innovation and business growth.
Company Leadership

CZ
CS
中源协和细胞基因工程股份有限公司, with stock code 600645, focuses on precision medicine to benefit humanity. The company operates in three main areas: precision prevention, precision diagnosis, and cell therapy, providing comprehensive health management services throughout the life cycle. Its core business includes cell testing, preparation and storage, in vitro diagnostic materials, and clinical applications of stem cells and immune cells. With multiple subsidiaries globally, it aims to create a precision medical industry platform that contributes to advancements in life sciences and enhances global health standards.
Company Leadership ZY
HW
ZW
SY
The Institute for Defense Analyses (IDA) is a private, nonprofit organization based in Alexandria, Virginia, that provides rigorous, independent, and objective analyses on defense and space issues. IDA serves various sponsors across the federal government, focusing on enhancing national security through research and policy analysis. Their intended clients include government agencies and organizations involved in defense, science, and technology. IDA is committed to delivering trusted expertise and service to the nation.
Company Leadership NN
HP
MF
IT